MSCs are able to release a large number of cytokines to exert their tumor regulatory effects, such as interleukin-6 (IL-6), insulin-like growth factor 1 (IGF-1) or vascular epidermal growth factor (VEGF) (Wang et al., 2009; Jurisic, 2020). The gene discussed is IL6; the disease is neoplasm.